85 results
Page 3 of 5
6-K
EX-99.1
awp28k70q3f7 q3k
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
F-3
z1zny35p6br211e4y9rt
7 Aug 19
Shelf registration (foreign)
12:00am
6-K
EX-99.1
q1zvobphxi
6 Aug 19
Notice of Annual and Special Meeting of Shareholders
12:00am
POS AM
3ys1h 9du
15 Jul 19
Prospectus update (post-effective amendment)
5:15pm
6-K
x490w98fsihfm
5 Jul 19
Current report (foreign)
9:00am
6-K
EX-99.1
qtgu0h5j
21 May 19
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
7:31am
6-K
EX-99.1
iwuq79e0ttb1bkeph
14 Feb 19
At Market Issuance Sales Agreement
8:13am
424B5
39fwvnps k7
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
EX-99.1
3bix2l06q4voyi4p00uu
31 Dec 18
Current report (foreign)
8:00am
6-K
edc3f4xsftemplnfbw
15 Oct 18
Current report (foreign)
5:15pm
POS AM
ziwqmw9k6ox3 sn8e
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
6-K
EX-99.1
egwhotge
11 Oct 18
Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares
7:42am
6-K
EX-99.1
nvwaet8tys6
9 Oct 18
Current report (foreign)
5:21pm
424B5
ngw95 h4kxipm04
5 Oct 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
sgxwhq7
4 Oct 18
Acasti Pharma Announces Pricing of $16.6 Million Underwritten Public Offering of Common Shares
11:00am
6-K
EX-99.1
z63u2dxw
3 Oct 18
Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares
5:15pm
424B5
xobjc mwmrho20
3 Oct 18
Prospectus supplement for primary offering
4:51pm
6-K
EX-99.1
ng1xc
14 Aug 18
Current report (foreign)
7:00am
6-K
EX-99.2
9xt7jbwx82h08p
1 Aug 18
Notice of Annual and Special Meeting of Shareholders
12:00am